Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

How to Tell When A Drug Company Fibs About Clinical Trial Results
TheStreet.com
Friday, July 6, 2012 - 12:49pm
tags:
Osiris, clinical trials
Why the Street Should Love ViroPharma's Earnings
Motley Fool
Friday, July 6, 2012 - 12:47pm
tags:
ViroPharma, earnings
An Assault On Vertex, Enthusiasm Building Around Xoma
Seeking Alpha
Friday, July 6, 2012 - 12:46pm
tags:
Xoma, Vertex
Seven pharma companies partner with Gates Foundation to speed TB drug discovery
Yahoo/Fly on the Wall
Friday, July 6, 2012 - 12:45pm
tags:
tuberculosis, Bill Gates, Abbott Laboratories, AstraZeneca, Bayer, Eli Lilly, GSK, Merck, Sanofi
Settlement unveils fed's leash on Glaxo manufacturing
Fierce Pharma Manufacturing
Friday, July 6, 2012 - 11:22am
tags:
GSK, drug manufacturing
NICE turns down Avastin for breast cancer
Fierce Pharma
Friday, July 6, 2012 - 11:20am
tags:
Avastin, Roche, breast cancer, NICE, UK
K-V says it will go bankrupt without FDA intervention
Fierce Pharma
Friday, July 6, 2012 - 11:19am
tags:
KV Pharmaceutical, FDA, Makena
Sucampo Pharmaceuticals Announces Arbitration Decision on Amitiza
Yahoo
Friday, July 6, 2012 - 11:17am
tags:
Amitiza, Sucampo, Takeda
Forest Labs Seen Needing Deal Amid Patent Losses: Real M&A
Bloomberg
Friday, July 6, 2012 - 11:03am
tags:
patents, M&A, Forest Labs
ShangPharma rallies 15% on buyout offer
Marketwatch
Friday, July 6, 2012 - 11:02am
tags:
ShangPharma
7 Fast Growing Small Cap Biotech Stocks With Analyst Confidence
Seeking Alpha
Friday, July 6, 2012 - 11:01am
tags:
Acorda, Cadence Pharmaceuticals, EXACT Sciences, Merrimack Pharmaceuticals, Nektar, Santarus, Threshold Pharmaceuticals
MannKind Fights On With Its Diabetes Game-Changer Afrezza
Seeking Alpha
Friday, July 6, 2012 - 10:59am
tags:
diabetes, Afrezza, inhaled insulin, MannKind
Dividend Payer PDL BioPharma May Be A Great Stock For The Slowdown
Seeking Alpha
Friday, July 6, 2012 - 10:59am
tags:
PDL Biopharma, dividends
These 2 Big Pharma Stocks Will Leap By 2013 (BMY, PFE)
Seeking Alpha
Friday, July 6, 2012 - 10:44am
tags:
Abbott Laboratories, Amylin, Bristol-Myers Squibb, Novartis, Pfizer
Lilly gains extension on pediatric Cymbalta exclusivity
Reuters
Friday, July 6, 2012 - 9:51am
tags:
Eli Lilly
Prolor Biotech: A Good Leadership Team That Can Make A Company Profitable
Seeking Alpha
Thursday, July 5, 2012 - 5:24pm
tags:
Prolor
Amgen closes $315M buyout of KAI Pharmaceuticals
Yahoo/AP
Thursday, July 5, 2012 - 5:24pm
tags:
Amgen, M&A, KAI Pharmaceuticals
Once More With Feeling: Feds Hit Glaxo for $3 Billion -- Market Yawns
Forbes
Thursday, July 5, 2012 - 5:23pm
tags:
GSK
Roche's exit is latest sign that N.J. pharmaceutical industry is losing its edge
NorthJersey.com
Thursday, July 5, 2012 - 5:22pm
tags:
New Jersey, Roche
Glaxo Executives Cited in Case Now Lead Sanofi, Actelion
Bloomberg Businessweek
Thursday, July 5, 2012 - 5:21pm
tags:
GSK, Sanofi, Actelion, Advair

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.